Swati Maliwal resigned from the post of chief of the Delhi Commission for Women on Friday after the Aam Adami Party (AAP) nominated her as its candidate for the upcoming Rajya Sabha elections.
The decision to nominate Swati Maliwal, known for her advocacy for women’s rights, will mark her debut in parliamentary affairs.
Taking to X, she shared a video and captioned it with a line from the famous song from the Bollywood movie ‘Kabhi Kabhie’.
“Pal do pal meri kahani hai (My story will last only for a moment or two)… Today, with moist eyes, I said goodbye to the Delhi Women’s Commission. I didn’t realize how 8 years had passed here with the panel. I saw many ups and downs while living here. I dedicate every day to the welfare of Delhi and the country. The fight is not over, it is just beginning,” she said.
The Political Affairs Committee of the AAP on Friday finalized its candidates for the upcoming Rajya Sabha elections scheduled to take place in Delhi on January 19.
The committee nominated Maliwal as its candidate for the first time and renominated ND Gupta and jailed leader Sanjay Singh for a second term in the Upper House of Parliament.
Chaired by AAP National Convenor Arvind Kejriwal, the committee decided to endorse two existing members for re-nomination, whereas Sushil Kumar Gupta expressed his intent to redirect his focus towards the electoral politics of Haryana.
ND Gupta is the party treasurer, and Sushil Gupta is the AAP president of the Haryana unit. The state is expected to go to the polls later this year.
Kenya sends more officers to Haiti, reinforcing efforts to curb gang violence that has displaced…
Yoon Suk Yeol's detention was extended due to fears of evidence destruction in a martial…
The new underground missile base, capable of launching cruise missiles from advanced speedboats, underscores Iran's…
Iranian state media reports the judges were shot by an assailant who later took his…
In Chihuahua, migrants set mattresses ablaze in response to a raid aimed at clearing the…
Kennedy's petition to halt vaccine approval in 2021 sparked controversy, advocating against mRNA vaccines and…